Regulation of Genetic Engineering and Biopesticides in the United States
Monday Sept. 14th (2:30 - 4:30 PM)
Special Content Session is organized in partnership with Sidley Austin LLP
Sidley Austin’s Special Content Session will elucidate the Ag Biotech regulatory system in the U.S. in regard to genetically engineered crops, and will provide insights on possible changes that may result from the comprehensive evaluation of that system.
The area under cultivation with genetically engineered crops has risen globally for nineteen consecutive years. In 2014, there were 181.5 million hectares planted with genetically engineered crops, 73.1 million of which were in the U.S. The global market value of these crops was $15.7 billion. While the safety of GE crops, and the sustainability benefits that accrue from their cultivation, are not questioned by those who know the science, these crops are, nonetheless, subjected to strict regulatory scrutiny. The United States, which has the most rigorous and effective Ag Biotech regulatory program worldwide, has recently initiated a comprehensive evaluation of its Ag Biotech regulatory scheme, with the intent to update its regulatory approach to “ensure that the system is prepared for the future products of biotechnology.”
Sidley’s Special Content Session will additionally provide insights on the regulation of Biopesticides at the U.S. Environmental Protection Agency. Under U.S. law, the category of biopesticides includes biochemical and microbial pesticides, GE crops, and biostimulants. The global market for biopesticides has been estimated at $3.7 billion in 2017, much of which currently occurs in the United States. We will examine and provide insight into EPA’s regulatory processes for biopesticides, and possible future regulatory challenges.